Mercer Global Advisors
FENC icon

Mercer Global Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Mercer Global Advisors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3K Buy
+3,009
New +$24.6K ﹤0.01% 4560

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's FENC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 3,009 shares worth $32.3K. The stake represents ﹤0.01% of the portfolio and ranks #4560 among its holdings.

88 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Mercer Global Advisors held 3,009 shares of Fennec Pharmaceuticals worth $32.3K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4560 holding.
  • 88 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.